MIR3667

Across TCGA pan-cancer cohorts, MIR3667 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated MIR3667 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher MIR3667 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR3667 expression acts as an unfavorable survival marker, although some lineages such as DLBC and PAAD show a favorable association.

HNSC, KIRC, and ESCA are the cancer types where MIR3667 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	IV	0.468	0.683	.019	45	view →
KIRC	OS	Tertile	II,III,IV	0.663	0.801	.012	36	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
KIRP	OS	Tertile	III,IV	0.463	0.831	.008	30	view →
DLBC	OS	Median	All	1.000	0.524	.003	28	view →
UVM	OS	Tertile	III,IV	0.104	0.813	.001	27	view →
PAAD	OS	Tertile	II,III,IV	1.000	0.403	.011	18	view →
THCA	OS	Tertile	II,III,IV	0.869	0.987	.032	18	view →
TGCT	DFS	Tertile	II,III,IV	0.560	0.949	.024	18	view →
SKCM	OS	Tertile	All	0.587	0.286	.007	15	view →
READ	DFS	Tertile	IV	0.095	0.697	.014	9	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

MIR3667–HNSC (DFS)

Open the HNSC breakdown →